Pharmaceutical Industry Blog

Last Updated: September 11, 2026 TL;DR: Guyana names the regulators it leans on — the United States, Canada, the United Kingdom and Australia — and India is not among them. But it leans harder than any other CARICOM state on the Caribbean Regulatory System, which accepts a WHO-prequalified finished product as an eligibility route. Guyana has registered 164 CRS-recommended products since October 2017, against Haiti's five. The door is open; it is simply not the door marked CDS

Last Updated: September 11, 2026 TL;DR: The Comorian rulebook is eight days old. On 3 September 2026 ANAMEV published, for the first time in one place, eleven CTD dossier checklists, the marketing-authorisation form and five governing decisions. A decision is due within 90 days — but the clock starts when fees are paid, and the fee schedule is published nowhere. The commercial route is narrower still: the national list of licensed wholesalers has exactly one entry. Key Takeaw

Top Injectable Manufacturer in Fiji – Reliable Pharmaceutical Solutions Last Updated: September 10, 2026 TL;DR: Fiji publishes exactly which foreign regulators it recognises, and India is not among them. For government supply, the regulator's own routing table says a product both registered and manufactured outside a PIC/S country is not accepted for prequalification. The open doors are WHO prequalification of the product, or a marketing authorisation from a stringent or WHO-

Top Injectable Manufacturer in Djibouti – Reliable Pharmaceutical Solutions Last Updated: September 10, 2026 TL;DR: Djibouti publishes no list of foreign regulators it trusts. Its 1991 medicines law applies a country-of-origin test instead: an imported speciality may be registered only if it is already registered where it was made. That is unusually open to an Indian manufacturer — but the Ministry of Health's own strategy records that the registration system is not operated,

Last Updated: September 9, 2026 TL;DR: Eswatini is the market where our standing question stops working. We ask whether a country names the foreign regulators it leans on; Eswatini has not been operating a national registration system at all, so there is no decision for a foreign decision to be leaned into. The Ministry of Health's own 2021 policy says the country "is currently not actively registering medicines". What exists instead is a certificate test sitting on the impor

Last Updated: September 9, 2026 TL;DR: Mauritius answers the question we ask of every market — does it name the authorities it will lean on, and is India's CDSCO among them — with a list of the wrong noun. There is no published list of foreign regulatory agencies, but there is a statutory list of PHARMACOPOEIAS, and the Indian Pharmacopoeia is on it by name, in the Pharmacy Act itself. That is recognition of a book of standards, not of an agency, and it opens no fast track. T